[Skip to Content]
Accessibility
Wirral University Hospital NHS Foundation Trust

Site Search

  1. Choose Us
  2. For Research
  3. For Patients

  4. Skin

Atopic dermatitis

About

We are inviting patients with atopic dermatitis (atopic eczema, also called AD) who are starting treatment with nemolizumab (Nemluvio®) to take part in a research study. This study is called RE-UNITE-AD. 

Nemolizumab has been shown to be safe and effective in clinical trials and is approved for the treatment of atopic dermatitis. This study aims to collect information about how well the medication works and its safety when used in routine clinical practice.

Who can take part?

You may be eligible to take part if you:

  • Are under the care of the Dermatology Team at our hospital
  • Have a diagnosis of atopic dermatitis (eczema)
  • Are due to start treatment with nemolizumab (Nemluvio®)
  • Are willing and able to provide informed consent (or have a parent/guardian who can consent on your behalf)

What is involved?

If you decide to take part:

  • A member of the research team will discuss the study with you and answer any questions.
  • You will be asked to sign a consent form before any study information is collected.
  • Information about your medical history, eczema, other health conditions and current treatments will be collected from you and your medical records.
  • Your height, weight and skin type may be recorded.
  • You may be asked to complete questionnaires about your health and eczema symptoms using a tablet device. These questionnaires take approximately 20 to 25 minutes to complete.
  • Information about your treatment with nemolizumab, including any side effects, will be collected during routine clinic visits.

The study will last for 12 months. No additional hospital visits are required, as information will be collected during your routine appointments whenever possible.

If you miss a scheduled study visit, a member of the research team may contact you to arrange follow-up.

Participants may receive reimbursement of up to £155 for the time spent completing study questionnaires. Payments will be made by bank transfer or PayPal.

 

How do I take part?

If you are eligible, a member of the research team may approach you during a clinic appointment or contact you by letter to discuss the study.

 

Further information

Please contact the Research & Innovation Department:

Email: wih-tr.ResearchDepartment@nhs.net